| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 18,200 | 19,214 | 19,204 | 19,733 | | Cost of Revenue | 2,709 | 3,049 | 3,645 | 4,959 | | | Gross Profit |
-
| 16,165 | 15,559 | 14,774 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,658 | 7,221 | 5,800 | 5,766 | | Non Recurring |
-
| (916) | 916 |
-
| | Others | 3,273 | 2,879 | 1,721 | 2,456 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 6,981 | 7,122 | 6,552 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 5,560 | 6,981 | 7,122 | 6,552 | | Interest Expense | 1,700 | 1,765 | 1,900 | 2,357 | | Income Before Tax | 3,860 | 5,216 | 5,222 | 4,195 | | Income Tax Expense | 970 | 1,454 | 1,494 | 1,187 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,890 | 3,762 | 3,728 | 3,008 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,890 | 3,762 | 3,728 | 3,008 | | Preferred Stock And Other Adjustments | (336) | (338) | (150) |
-
| | | Net Income Applicable To Common Shares | $2,554 | $3,424 | $3,578 | $3,008 |
|
0.51% Nasdaq 
Income Statement
